BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7602343)

  • 1. Cardiac function in Wilms' tumor survivors.
    Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
    J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of left ventricular function by echocardiogram in patients with Wilms' tumor treated with anthracyclines versus those not so treated.
    Iarussi D; Indolfi P; Pisacane C; Casale F; Martino V; Fusco A; De Rosa E; Di Tullio MT; Calabrò R
    Am J Cardiol; 2003 Aug; 92(3):359-61. PubMed ID: 12888156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
    Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
    J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxic complications in Wilms' tumour survivors after treatment with anthracyclines].
    Balcerska A; Aleszewicz-Baranowska J; Adamkiewicz-Drozyńska E; Bień E; Sierota D; Kaczorowska B; Kołecki P; Kowalczyk J; Kurylak A; Stachowicz-Stencel T; Stefanska K; Szołkiewicz A
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):111-9. PubMed ID: 12021470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The late effects of anticancer therapy after childhood Wilm's tumor: the role of diastolic function and ambulatory blood pressure monitoring.
    Elli M; Sungur M; Genç G; Ayyildiz P; Dagdemir A; Pinarli FG; Acar S
    Jpn J Clin Oncol; 2013 Oct; 43(10):1004-11. PubMed ID: 23924525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study.
    Sorensen K; Levitt GA; Bull C; Dorup I; Sullivan ID
    Cancer; 2003 Apr; 97(8):1991-8. PubMed ID: 12673729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.
    Green DM; Grigoriev YA; Nan B; Takashima JR; Norkool PA; D'Angio GJ; Breslow NE
    J Clin Oncol; 2001 Apr; 19(7):1926-34. PubMed ID: 11283124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
    Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
    Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
    Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
    Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
    Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
    Lipshultz SE; Lipsitz SR; Mone SM; Goorin AM; Sallan SE; Sanders SP; Orav EJ; Gelber RD; Colan SD
    N Engl J Med; 1995 Jun; 332(26):1738-43. PubMed ID: 7760889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.
    Marx M; Langer T; Graf N; Hausdorf G; Stöhr W; Ludwig R; Beck JD
    Med Pediatr Oncol; 2002 Jul; 39(1):18-24. PubMed ID: 12116074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
    Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
    Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac toxicity 4 to 20 years after completing anthracycline therapy.
    Steinherz LJ; Steinherz PG; Tan CT; Heller G; Murphy ML
    JAMA; 1991 Sep; 266(12):1672-7. PubMed ID: 1886191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
    Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.